Scholarlink

Background <p>Pancreatic cancer remains one of the most lethal malignancies globally. In Africa, the burden is poorly characterized due to fragmented data and limited resources.</p> Objectives <p>This scoping review aimed to map published data on pancreatic cancer across the continent, identify reporting gaps, and highlight implications for research and policy.</p> Methods <p>A systematic search was conducted across PubMed, OVID Medline, CINAHL, ERIC, and Scopus for articles published between January 1995 and June 2025. Inclusion criteria focused on clinical data, treatment modalities, and survival outcomes of pancreatic cancer in African populations.</p> Results <p>Twenty studies spanning 1995–2023,representing 26,850 patients, were identified. Research output was geographically uneven, concentrated in South Africa, Egypt, Morocco. The weighted mean age at diagnosis was 59.2 years. Primary symptoms included Jaundice, abdominal pain, and weight loss. Advanced-stage presentation dominated, with stage III–IV accounting for &gt; 70% of reported cases. Staging data were missing for nearly 40% of the total cohort, and complete treatment pathways were reported in fewer than half of studies. Surgical resection rates remain low (&lt; 15% in most cohorts), and access to adjuvant chemotherapy is inconsistent. Survival data were rarely available, with median overall survival is notably poor, ranged between 3 and 12 months.</p> Conclusion <p>Pancreatic cancer in Africa is characterized by late-stage presentation and limited therapeutic options. Improving outcomes requires enhanced diagnostic infrastructure and region-specific clinical registries to guide evidence-based interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical Presentation and Management Outcomes of Pancreatic Cancer in African Countries: A Scoping Review

  • 期刊论文

  • 发表日期：

    2026年5月13日

查看全文
  • Mohamed Daffalla Awadalla Gismalla,
  • Moawia Mohammed Ali Elhassan,
  • Ahmed Abd Elrahman Abdalla Abd Elrahman,
  • Ali Yasen Mohamedahmed,
  • Mohamed Soud Mohamed Saadeldien,
  • Khalid Yousif Khalid Abu Aagla ,
  • Ahmed Mohammed Ali Ahmed,
  • Walid Elhaj Abdelrahim,
  • Anita Balakrishnan

摘要

Background

Pancreatic cancer remains one of the most lethal malignancies globally. In Africa, the burden is poorly characterized due to fragmented data and limited resources.

Objectives

This scoping review aimed to map published data on pancreatic cancer across the continent, identify reporting gaps, and highlight implications for research and policy.

Methods

A systematic search was conducted across PubMed, OVID Medline, CINAHL, ERIC, and Scopus for articles published between January 1995 and June 2025. Inclusion criteria focused on clinical data, treatment modalities, and survival outcomes of pancreatic cancer in African populations.

Results

Twenty studies spanning 1995–2023,representing 26,850 patients, were identified. Research output was geographically uneven, concentrated in South Africa, Egypt, Morocco. The weighted mean age at diagnosis was 59.2 years. Primary symptoms included Jaundice, abdominal pain, and weight loss. Advanced-stage presentation dominated, with stage III–IV accounting for > 70% of reported cases. Staging data were missing for nearly 40% of the total cohort, and complete treatment pathways were reported in fewer than half of studies. Surgical resection rates remain low (< 15% in most cohorts), and access to adjuvant chemotherapy is inconsistent. Survival data were rarely available, with median overall survival is notably poor, ranged between 3 and 12 months.

Conclusion

Pancreatic cancer in Africa is characterized by late-stage presentation and limited therapeutic options. Improving outcomes requires enhanced diagnostic infrastructure and region-specific clinical registries to guide evidence-based interventions.